Inuvo, Inc. Announces Proposed Public Offering of Common Stock
LITTLE ROCK, Ark., July 22, 2020 (GLOBE NEWSWIRE) -- INUVO, INC. (NYSE AMERICAN: INUV) (“Inuvo” or the “Company”), a leading provider of marketing technology, powered by IntentKeyTM artificial
intelligence that serves brands and agencies, today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. As part of this offering, Inuvo
intends to grant the underwriters a 45-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. The offering is subject to
market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the proposed offering
are to be sold by Inuvo.
A.G.P./Alliance Global Partners is acting as sole book-running manager for the offering.
Inuvo intends to use the net proceeds from this offering for working capital and to fund other general corporate purposes.
Lesen Sie auch
This offering is being made pursuant to an effective shelf registration statement on Form S-3 (No. 333-239147) previously filed with the U.S. Securities and Exchange Commission (the “SEC”) that was declared effective by the SEC on June 25, 2020. A preliminary prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. Electronic copies of the preliminary prospectus supplement may be obtained, when available, from A.G.P./Alliance Global Partners, 590 Madison Avenue, 28th Floor, New York, NY 10022 or via telephone at 212-624-2006 or email: prospectus@allianceg.com. Before investing in this offering, interested parties should read in their entirety the prospectus supplement and the accompanying prospectus and the other documents that Inuvo, Inc. has filed with the SEC that are incorporated by reference in such prospectus supplement and the accompanying prospectus, which provide more information about Inuvo, Inc. and such offering. The final terms of the proposed offering will be disclosed in a final prospectus supplement to be filed with the SEC.